Meanwhile, revenue totaled $14.66 million, significantly exceeding the $9.5 million analyst consensus. While this represents a narrower band compared to the previous $355 million to $445 million range, the floor increased unfavorably. Analyst projections had anticipated a 2026 EBITDA loss of $427.1 million, placing it comfortably within the company’s revised guidance corridor. It operates in the nascent stages of commercialization, with annual revenue guidance remaining in the lower double-digit millions. With projected revenue between $42 million and $50 million set against a potential $445 million EBITDA loss, the rate of capital consumption remains substantial.